Retatrutide is a synthetic triple-receptor agonist peptide targeting the GLP-1 receptor (GLP-1R), glucose-dependent insulinotropic polypeptide receptor (GIPR), and glucagon receptor (GCGR) simultaneously, studied extensively across metabolic biology, obesity research, energy expenditure, and cardiovascular science for its unmatched tri-agonist incretin action and superior metabolic influence compared to single and dual-receptor compounds making it the most advanced and broadly acting incretin research peptide currently available in modern metabolic science
These are meant to be indefinite medications, said Joshua Neal, M.D., chief of the MUSC Health Wellness and Human Performance Integrated Center of Clinical Excellence (ICCE) and an obesity medicine physician
Empower Pharmacy tirzepatide is one of the more well-known compounding options
Being proactive about safety means talking openly with patients about their concerns and is key to identifying trouble early
After two pregnancies, she found it hard to return to a healthy weight despite rigorous diet and training
Are they right for you
.jpg)
